Innoviva Inc (INVA)
15.26
+0.28
(+1.83%)
USD |
NASDAQ |
Apr 26, 16:00
15.26
0.00 (0.00%)
After-Hours: 20:00
Innoviva Cash from Financing (TTM): -171.84M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -171.84M |
September 30, 2023 | -167.25M |
June 30, 2023 | -252.33M |
March 31, 2023 | -252.86M |
December 31, 2022 | -55.57M |
September 30, 2022 | -57.63M |
June 30, 2022 | 33.67M |
March 31, 2022 | -370.86M |
December 31, 2021 | -452.50M |
September 30, 2021 | -442.94M |
June 30, 2021 | -438.09M |
March 31, 2021 | -35.46M |
December 31, 2020 | -29.78M |
September 30, 2020 | -41.03M |
June 30, 2020 | -51.49M |
March 31, 2020 | -39.66M |
December 31, 2019 | -23.78M |
September 30, 2019 | -12.41M |
June 30, 2019 | -114.18M |
March 31, 2019 | -115.10M |
December 31, 2018 | -237.97M |
September 30, 2018 | -322.65M |
June 30, 2018 | -221.33M |
March 31, 2018 | -277.45M |
December 31, 2017 | -163.19M |
Date | Value |
---|---|
September 30, 2017 | -95.72M |
June 30, 2017 | -109.63M |
March 31, 2017 | -79.59M |
December 31, 2016 | -97.57M |
September 30, 2016 | -103.76M |
June 30, 2016 | -104.52M |
March 31, 2016 | -105.56M |
December 31, 2015 | -106.92M |
September 30, 2015 | -90.90M |
June 30, 2015 | -73.15M |
March 31, 2015 | 103.09M |
December 31, 2014 | 149.07M |
September 30, 2014 | 171.84M |
June 30, 2014 | 293.28M |
March 31, 2014 | 168.25M |
December 31, 2013 | 397.84M |
September 30, 2013 | 391.54M |
June 30, 2013 | 290.39M |
March 31, 2013 | 481.26M |
December 31, 2012 | 235.87M |
September 30, 2012 | 232.00M |
June 30, 2012 | 220.89M |
March 31, 2012 | 16.41M |
December 31, 2011 | 25.60M |
September 30, 2011 | 156.09M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-452.50M
Minimum
Dec 2021
33.67M
Maximum
Jun 2022
-156.63M
Average
-57.63M
Median
Sep 2022
Cash from Financing (TTM) Benchmarks
NovaBay Pharmaceuticals Inc | 1.91M |
Palatin Technologies Inc | 5.553M |
iBio Inc | 10.68M |
Theriva Biologics Inc | 0.625M |
Oragenics Inc | 0.2839M |